Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1129-2377
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Pharmacokinetics of sumatriptan in non-respondent and in adverse drug reaction reporting migraine patients ; volume:6 ; number:4 ; day:20 ; month:7 ; year:2005 ; pages:319-321 ; date:9.2005
The journal of headache and pain ; 6, Heft 4 (20.7.2005), 319-321, 9.2005

Urheber
Sternieri, E.
Beteiligte Personen und Organisationen
Pinetti, D.
Coccia, C. P. R.
Leone, S.
Bertolini, A.
Ferrari, A.
SpringerLink (Online service)

DOI
10.1007/s10194-005-0220-z
URN
urn:nbn:de:1111-2016040818398
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:55 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Sternieri, E.
  • Pinetti, D.
  • Coccia, C. P. R.
  • Leone, S.
  • Bertolini, A.
  • Ferrari, A.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Positiones Respondent

Kapitel

Positiones Respondent

Standardizing adverse drug event reporting data

Standardizing adverse drug event reporting data

Respondent-Driven Sampling

Artikel

Respondent-Driven Sampling

Respondent driven sampling

Arbeitspapier

Respondent driven sampling

Respondent driven sampling

Arbeitspapier

Respondent driven sampling

Respondent driven sampling

Respondent driven sampling

Respondent-Driven Sampling

Respondent-Driven Sampling

Respondent driven sampling

Respondent driven sampling

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine

Seasonal and Geographic Variation in Adverse Event Reporting

Seasonal and Geographic Variation in Adverse Event Reporting

Sex differences in pharmacokinetics predict adverse drug reactions in women

Sex differences in pharmacokinetics predict adverse drug reactions in women

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database

Verbundene Objekte